Page last updated: 2024-10-19

racemethionine and Polycythemia Vera

racemethionine has been researched along with Polycythemia Vera in 1 studies

Racemethionine: A preparation of METHIONINE that includes a mixture of D-methionine and L-methionine isomers.

Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.

Research Excerpts

ExcerptRelevanceReference
"11 C-methionine PET/CT for parathyroid adenoma localization on a 60-year-old woman known with polycythemia vera revealed highly methionine-avid red bone marrow, an uptake pattern that has previously been described in hematological disease such as multiple myeloma."8.31Skeletal "Superscan" With 11 C-Methionine PET/CT in Polycythemia Vera. ( Arveschoug, AK; Jochumsen, MR; Madsen, MA, 2023)
"11 C-methionine PET/CT for parathyroid adenoma localization on a 60-year-old woman known with polycythemia vera revealed highly methionine-avid red bone marrow, an uptake pattern that has previously been described in hematological disease such as multiple myeloma."4.31Skeletal "Superscan" With 11 C-Methionine PET/CT in Polycythemia Vera. ( Arveschoug, AK; Jochumsen, MR; Madsen, MA, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jochumsen, MR1
Madsen, MA1
Arveschoug, AK1

Other Studies

1 other study available for racemethionine and Polycythemia Vera

ArticleYear
Skeletal "Superscan" With 11 C-Methionine PET/CT in Polycythemia Vera.
    Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4

    Topics: Female; Humans; Methionine; Middle Aged; Polycythemia Vera; Positron Emission Tomography Computed To

2023